Literature DB >> 22963428

Quantifying the cost of laparoscopic inguinal hernia repair.

Philip Smart1, Lindsay Castles.   

Abstract

BACKGROUND: Laparoscopic inguinal hernia repair has been widely adopted. While the clinical advantages and disadvantages are well-quantified, the economic cost is less well-studied.
METHODS: A retrospective audit and case review of a single-centre public hospital consecutive case series was performed using data captured from real-time stock usage tracking technology and review of electronic medical records.
RESULTS: Laparoscopic inguinal hernia repair requires 11-min (21%) extra theatre time and costs $1268 (370%) more for single-use disposable equipment and prostheses.
CONCLUSIONS: Laparoscopic inguinal hernia repair does not require significantly more theatre time, but has a higher short-term in-hospital cost. Repair technique should be tailored according to patient factors.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Year:  2012        PMID: 22963428     DOI: 10.1111/j.1445-2197.2012.06189.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  4 in total

Review 1.  Current status of single-port versus multi-port approach in laparoscopic inguinal hernia mesh repair: an up-to-date systematic review and meta-analysis.

Authors:  K Perivoliotis; G Tzovaras; C Sarakatsianou; I Baloyiannis
Journal:  Hernia       Date:  2019-01-07       Impact factor: 4.739

2.  A preoperative hernia symptom score predicts inguinal hernia anatomy and outcomes after TEP repair.

Authors:  Robert D Knox; Christophe R Berney
Journal:  Surg Endosc       Date:  2015-02       Impact factor: 4.584

3.  International guidelines for groin hernia management.

Authors: 
Journal:  Hernia       Date:  2018-01-12       Impact factor: 4.739

4.  Assessment of gel-coated delayed self-gripping mesh.

Authors:  Avinoam Nevler; Mordechai Gutman; Alexander Lebedyev
Journal:  JSLS       Date:  2014 Oct-Dec       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.